Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5  (01-2003)

Period of time： 2003年5期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 27

E-ISSN： 1875-5968|3|5

ISSN： 1568-0118

Subject： R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5

Menu

Preface [ Hot Topic: Radiation Oncology as Mainstay of Modern Cancer Medicine (Guest Editors: Claus Belka & Verena Jendrossek)]

Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-09 , pp. i-ii

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Preface [ Hot Topic: Radiation Oncology as Mainstay of Modern Cancer Medicine (Guest Editors: Claus Belka Verena Jendrossek)]

Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-09 , pp. ii-ii

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Disruption of Cell Death Signaling in Cancer: Impact on Disease Prognosis and Response to Therapy

Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-09 , pp. 319-326

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor Strategies to Enhance Radiation Action

Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-09 , pp. 327-333

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Death Receptor Ligands: New Strategies for Combined Treatment with Ionizing Radiation

Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-09 , pp. 334-342

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Membrane Targeted Anticancer Drugs: Potent Inducers of Apoptosis and Putative Radiosensitisers

Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-09 , pp. 343-353

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

New Targets for the Modulation of Radiation Response - Selective Inhibition of the Enzyme Cyclooxygenase 2

Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-09 , pp. 354-359

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Radioprotection of Normal Tissue to Improve Radiotherapy: The Effect of the Bowman Birk Protease Inhibitor

Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-09 , pp. 360-363

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Hypoxic Radiosensitizers and Hypoxic Cytotoxins in Radiation Oncology

Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-09 , pp. 364-374

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Antiangiogenesis and Radiotherapy: What Is the Role of Combined Modality Treatment?

Current Medicinal Chemistry - Anti-Cancer Agents,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-01 , pp. 375-382

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 10 item(s)